Serum Lipocalin 2 (Neutrophil Gelatinase-Associated Lipocalin) in Relation to Biomarkers of Inflammation and Cardiac Stretch During Activation of the Renin-Angiotensin-Aldosterone System in Human Immunodeficiency Virus.
BNP
HIV
inflammation
lipocalin 2
renin-angiotensin-aldosterone system
Journal
The Journal of infectious diseases
ISSN: 1537-6613
Titre abrégé: J Infect Dis
Pays: United States
ID NLM: 0413675
Informations de publication
Date de publication:
26 09 2019
26 09 2019
Historique:
received:
19
04
2019
accepted:
10
07
2019
pubmed:
13
7
2019
medline:
20
5
2020
entrez:
13
7
2019
Statut:
ppublish
Résumé
To evaluate the relationship of lipocalin 2 to inflammation and cardiac injury with increased aldosterone in human immunodeficiency virus (HIV). A standardized 6-day low-sodium diet was used to stimulate renin-angiotensin-aldosterone system (RAAS) activation, and serum lipocalin 2 and biomarkers of inflammation and cardiac stretch were assessed among persons with or without HIV. Lipocalin 2 levels increased with RAAS activation compared with suppression in the HIV group (median level [interquartile range], 71.3 [59.2-99.7] vs 67.0 [51.8-86.3] ng/mL; P = .01). During RAAS activation, lipocalin 2 was related to biomarkers of inflammation (tumor necrosis factor α [P = .007]), monocyte/macrophage activation (soluble CD163 [P = .005] and chemokine [C-C motif] ligand 2 [P = .03]), and markers of cardiac stretch (brain natriuretic peptide [P < .001] and N-terminal fragment of the prohormone brain natriuretic peptide [P = .001]) in HIV. Lipocalin 2 may be important in modulating aldosterone-induced inflammation, monocyte activation, and cardiac stretch during RAAS activation in HIV. NCT01407237.
Identifiants
pubmed: 31298286
pii: 5531600
doi: 10.1093/infdis/jiz346
pmc: PMC6761935
doi:
Substances chimiques
Biomarkers
0
LCN2 protein, human
0
Lipocalin-2
0
Banques de données
ClinicalTrials.gov
['NCT01407237']
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
1420-1424Subventions
Organisme : NIDDK NIH HHS
ID : P30 DK040561
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR000170
Pays : United States
Organisme : NCRR NIH HHS
ID : UL1 RR025758
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002541
Pays : United States
Organisme : NHLBI NIH HHS
ID : K24 HL103845
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK049302
Pays : United States
Organisme : NHLBI NIH HHS
ID : T32 HL007609
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001102
Pays : United States
Organisme : NHLBI NIH HHS
ID : K23 HL136262
Pays : United States
Informations de copyright
© The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.
Références
Arterioscler Thromb Vasc Biol. 2014 Nov;34(11):2457-64
pubmed: 25189569
BMC Infect Dis. 2018 Jan 5;18(1):10
pubmed: 29304747
J Infect Dis. 2016 Nov 1;214(9):1336-1340
pubmed: 27549584
Circ Heart Fail. 2014 Jan;7(1):35-42
pubmed: 24347663
Eur J Heart Fail. 2011 Aug;13(8):846-51
pubmed: 21791540
J Am Coll Cardiol. 2012 Mar 20;59(12):1101-9
pubmed: 22421304
J Mol Cell Cardiol. 2018 Feb;115:32-38
pubmed: 29289651
JCI Insight. 2018 Sep 6;3(17):
pubmed: 30185654
Hypertension. 2017 Dec;70(6):1148-1156
pubmed: 29061727
Trends Endocrinol Metab. 2017 May;28(5):388-397
pubmed: 28214071
Hypertension. 2015 Jul;66(1):158-66
pubmed: 25987661
J Clin Endocrinol Metab. 2015 Aug;100(8):2873-82
pubmed: 26086328
J Acquir Immune Defic Syndr. 2012 Feb 1;59(2):e24-5
pubmed: 22245717
Arterioscler Thromb Vasc Biol. 2014 Sep;34(9):2135-42
pubmed: 24969771
Hypertension. 2012 May;59(5):966-72
pubmed: 22469622